论文部分内容阅读
近年来国内外通过大量的实验研究和临床观察,发现血浆中分子物质(MMS)在多种疾病中均有变化。为此,我们观察了51例糖尿病与30例健康人血浆MMS含量的变化,并就其临床意义作一探讨。 1 对象与方法 1.1 对象 正常对照组:体检健康成人30例,其中男16例,女14例,年龄17~65岁,平均48岁。糖尿病组:51例,其中男23例,女28例,年龄19~72岁,平均50岁,病程1个月~15年。均系本院住院患者,按WHO诊断标准,经临床和实验室检查确诊。根据病情分为三组:A组无症状或症状轻,空腹血糖<8.3mmol/L;B组介于轻型与重型之间;C组症状明显,空腹血糖>13.8mmol/L。
In recent years, both at home and abroad through a large number of experimental studies and clinical observations, found that plasma molecular substances (MMS) in a variety of diseases have changed. To this end, we observed 51 cases of diabetes and 30 healthy subjects plasma MMS content changes, and to explore its clinical significance. 1 objects and methods 1.1 object normal control group: 30 healthy adult examination, including 16 males and 14 females, aged 17 to 65 years, mean 48 years. Diabetic group: 51 cases, including 23 males and 28 females, aged 19 to 72 years, mean 50 years, duration of 1 month to 15 years. All patients hospitalized in our hospital, according to WHO diagnostic criteria, diagnosed by clinical and laboratory tests. According to the disease, the patients were divided into three groups: group A asymptomatic or with mild symptoms, fasting blood glucose <8.3mmol / L; group B between light and heavy; group C with obvious symptoms and fasting blood glucose> 13.8mmol / L.